7 Somatomedin activity in disorders of nutrition and metabolism

Clinics in Endocrinology and Metabolism

Volumn 13, Issue 1, 1984, Pages 145-189

  Phillips, L S ^a   Unterman, T G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; INSULIN; SOMATOMEDIN;

DIAGNOSIS; ENDOCRINE SYSTEM; ETIOLOGY; HUMAN; LIVER; PREVENTION; REVIEW; THERAPY;

ADRENAL CORTEX HORMONES; ADRENAL GLAND HYPERFUNCTION; ANIMAL; CARTILAGE; DIABETES MELLITUS; ENERGY METABOLISM; FASTING; FOOD; GROWTH; GROWTH DISORDERS; GROWTH HORMONE; HUMAN; HYDROCORTISONE; HYPERINSULINISM; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, CHRONIC; LIVER; MODELS, BIOLOGICAL; NUTRITION DISORDERS; SOMATOMEDINS; SUPPORT, U.S. GOV'T, P.H.S.; THYROID HORMONES; UREMIA;

EID: 0021356418     PISSN: 0300595X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-595X(84)80012-2     Document Type: Article

References (217)

1. Cell-free synthesis of rat insulin-like growth factor II
2. Adrenal function in malnutrition
3. Growth hormone in malnutrition
4. Effects of glucocorticoids on body growth and serum levels of somatomedin A in the rat
5. Release of somatomedin-like activity by cultured WI-38 human fibroblasts
6. Somatomedin inhibitors in diabetic rat serum
7. Impact of home blood glucose monitoring on childhood diabetes
8. Association between serum insulin, serum somatomedin and liver receptors for human growth hormone in streptozotocin diabetes
9. Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure
10. Somatogenic receptors of rat liver: regulation by insulin
11. The effect of fasting on liver receptors for prolactin and growth hormone
12. Growth hormone and malnutrition: the Chilean experience
13. Somatomedin C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary
14. Growth pattern and dietary intake of children with chronic renal insufficiency
15. Role of dietary energy supplementation in growth of children with chronic renal insufficiency
16. Somatomedin production by rat liver in organ culture. III. Studies on the release of insulin-like growth factor and its carrier protein measured by radioligand assays. Effects of growth hormone, insulin and cortisol
17. Somatomedin production by rat liver in organ culture. II. Studies of cartilage sulphation inhibitors released by the liver and their separation from somatomedins
18. Somatomedin production by rat liver in organ culture I. Validity of the technique. Influence of the released material on cartilage sulphation. Effects of growth hormone and insulin
19. Growth in juvenile diabetes mellitus
20. Effect of pubertal stage and recent blood glucose control on plasma somatomedin C in children with insulin-dependent diabetes mellitus
21. Plasma somatomedins, endogenous insulin secretion, and growth in transient neonatal diabetes mellitus
22. Effect of prolonged cortisone therapy on the statural growth skeletal maturation and metabolic status of children
23. The influence of malnutrition on the postprandial metabolic rate and respiratory quotient
24. Growth in children with renal insufficiency
25. 3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion
26. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats
27. Enteroinsular axis and relationship between insulin and growth hormone in the normal and obese child
28. Hormone-fuel interrelationships during fasting
29. Evolution de l'activite somatomedine du serum pendant la cure de restriction calorique chez l'enfant obese
30. Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts
31. Reduction of plasma immunoreactive somatomedin C during fasting in humans
32. Growth hormone studies in Cushing's syndrome
33. Craniopharyngioma: the role of insulin in promoting postoperative growth
34. Growth as a measurement of control in the management of diabetic children
35. 14 to labeled hydroxyproline by rat cartilage in vitro: effects of hypophysectomy, growth hormone and cortisol
36. The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver
37. Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome
38. Evidence that somatomedin is synthesized by multiple tissues in the fetus
39. Some effects of accelerating growth. II. Skeletal development
40. Effects of starvation on plasma GH activity, pituitary GH and GH-RF levels in the rat
41. Growth body weight and insulin requirement in diabetic children
42. Height and skeletal maturity in children with newly-diagnosed juvenile-onset diabetes
43. Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy
44. Glucocorticoid therapy in children
45. Increase in cell number as a factor in the growth of the organs and tissues of the young male rat
46. Growth and bone age of juvenile diabetics
47. Childhood asthma and steroid-therapy as influences on growth
48. Insulin secretion in acromegaly
49. Nutrition and growth
50. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats
51. Human growth hormone: clinical measurement, response to hypoglycemia and suppression by corticosteroids
52. Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage
53. Estimation of somatomedin C levels in normals and patients with pituitary disease by radioimmunoassay
54. The radioimmunoassay for somatomedin C
55. Fat thickness and developmental status in childhood and adolescence
56. Serum triiodothyronine in undernourished rats: dependence on dietary composition rather than total calorie or protein intake
57. Influence of food deprivation and adrenal steroids on DNA synthesis in various mammalian tissues
58. Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding
59. Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy
60. Reduced sulphation factor in undernourished children
61. Nutrition and restricted nutrition
62. Pharmacokinetic studies of prednisolone in children
63. Effect of human growth hormone in kwashiorkor and marasmus
64. Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon, and growth hormone in normals and juvenile diabetics
65. Biochemical characteristics of different forms of protein-energy malnutrition: an experimental model using young rats
66. Treatment with essential amino acids in patients on chronic hemodialysis: a double blind cross-over study
67. Pathogenetic aspects of the obese-hyperglycemic syndrome in mice (Genotype ob ob): II. Extrapancreatic factors
68. The growth hormone dependent incorporation of sulphate into the costal cartilage of obese-hyperglycaemic mice of different ages
69. Rapid effects of single small doses of l-thyroxine and triiodo-l-thyronine on growth hormone, as studied in the rat by radioimmunoassay
70. Effects of cortisol on cell proliferation and proteoglycan synthesis and degradation in cartilage zones of the calf costochondral growth plate in vitro with and without rat plasma somatomedin activity
71. Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition
72. Cellularity of rat adipose tissue: effects of growth, starvation and obesity
73. Metabolic and nutritional factors in children with renal insufficiency
74. Normal growth with subnormal growth hormone levels
75. Growth hormone and somatomedin in insulin-dependent diabetes mellitus
76. Dietary components that regulate serum somatomedin C concentrations in humans
77. Does control influence the growth of diabetic children?
78. Growth development and prognosis for diabetic children
79. Nutritional basis of growth failure in children and adolescents with Crohn's disease
80. Somatomedin deficiency: a possible cause of growth failure in children with chronic inflammatory bowel disease
81. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral rehabilitation
82. Effect of GH and insulin on the generation of somatomedin by perfused rat liver
83. Abnormal amino acid metabolism in uremia
84. In vitro effects of growth hormone on the number and activity of ribosomes engaged in protein synthesis in the isolated rat diaphragm
85. Comparison of the effects of growth hormone and somatomedin on skeletal muscle metabolism
86. Growth hormone and cortisol responsiveness in Cushing's syndrome
87. Linear growth and insulin dose as indices of control in children with diabetes mellitus
88. Insulin, growth and growth hormone
89. Low serum somatomedin-activity in celiac disease
90. Short stature as the only clinical sign of Cushing's syndrome
91. Somatomedin activity in cystic fibrosis and reserpinized rats: possible explanation for growth retardation
92. Growth in children with renal failure
93. Production of somatomedin activity in vitro in the presence of growth hormone and cyclohexamide
94. Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism
95. Nonsuppressible insulin-like activity in rat organs as detected by fluorescent antibody and radioimmunoassay techniques
96. Progressive changes in serum cortisol, insulin and growth hormone concentrations and their relationship to the distorted amino acid pattern during the development of kwashiorkor
97. The effect of cortisone acetate on the course of development of experimental protein-energy malnutrition in rats
98. The relationship between hormonal balance and growth in malnourished children and rats
99. Critical periods of growth
100. The production of ‘sulphation factor’ by rat liver
101. Preliminary studies of ‘sulphation factor’ production by rat kidney
102. Production of sulphation factor by the perfused liver
103. Circulating NSILAs in man: preliminary studies of stimuli in vivo and of binding to plasma components
104. Growth in renal failure
105. Insulin-like growth factors in the fed and fasted states
106. Role of the liver in regulating somatomedin activity: effects of streptozotocin diabetes and starvation on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver
107. Relation of purified pituitary growth hormone and insulin in regulation of nitrogen balance
108. In vitro effect of the kidney on somatomedin activity
109. Plasma growth hormone concentration in corticosteroid-treated children
110. Metabolic effects of human growth hormone in corticosteroid-treated children
111. Cartilage sulfation and serum somatomedin in rats during and after cortisone-induced growth arrest
112. Growth hormone, somatomedin and cartilage sulfation in failure of catch-up growth after propylthiouracilinduced hypothyroidism in the rat
113. The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn's disease and growth failure
114. Effects of dietary energy restriction and rehabilitation on growth and tissue composition in growing rats
115. Relative energy requirements for maintenance, growth and physical activity
116. Nutritional regulation of somatomedin activity and growth
117. Nutrition, metabolism and growth
118. Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function
119. Nutrition and somatomedin. III. Diabetic control, somatomedin and growth in rats
120. Nutrition and somatomedin. IX. Blunting of insulin-like activity by inhibitor in diabetic rat serum
121. Somatomedins
122. Circulating growth factor studies in growth plate versus resting cartilage in vitro: tissue responsiveness
123. Nutrition and somatomedin. I. Effect of fasting and refeeding on serum somatomedin activity and cartilage growth activity in rats
124. Nutrition and somatomedin. I. Effect of fasting and refeeding on serum somatomedin activity and cartilage growth activity in rats
125. Nutrition and somatomedin, II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats
126. Nutrition and somatomedin. V. Action and measurement of somatomedin inhibitor(s) in serum from diabetic rats
127. Increased somatomedin inhibitors in renal failure
128. Steroid hormone effects on somatomedin. I. Somatomedin action in vitro
129. Somatomedin and nutrition. IV. Regulation of somatomedin activity and growth cartilage activity by quantity and composition of diet in rats
130. Nutrition and somatomedin. VIII. The ‘somatomedin inhibitor’ in diabetic rat serum is a general growth cartilage inhibitor
131. Somatomedin activity and inorganic sulfate in children undergoing dialysis
132. Nutrition and somatomedin. VI. Somatomedin activity and somatomedin inhibitory activity in serum from normal and diabetic rats
133. Human growth hormone and sulphation factor in protein-calorie malnutrition
134. Insulin secretion in protein-calorie malnurition
135. Some aspects of growth in diabetic children
136. Growth hormone receptors in rat liver memberanes: effects of fasting and refeeding and correlation with plasma somatomedin activity
137. Statural growth of children with renal disease
138. The effect of administered corticosteroids on the growth of children
139. Relationship of serum immunoreactive somatomedin C to dietary protein intake and energy in growing rats
140. Serum somatomedin activity and cartilage metabolism in acutely fasted, chronically malnourished, and refed rats
141. Growth hormone secretion in protein-calorie malnutrition
142. Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities
143. Somathormone et activité somatomedine plasmatique au cours des amaigrissements graves de l'anorexie mentale chez l'enfant
144. Somatomedin activity in children with growth retardation with special reference to nutrition
145. Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia
146. Insulin resistance in noninsulin-dependent diabetes
147. Characterization of a somatomedin (insulin-like growth factors) synthesized by fetal rat liver organ cultures
148. Interactions of insulin-like growth factors I and II and multiplication-Stimulating activity with receptors and serum carrier proteins
149. Effects of dietary composition on somatomedin activity in growing rats
150. Prenatal exposure to prednisone in humans and animals retards intrauterine growth
151. Skeletal growth in uremia
152. Fasting and postprandial levels of plasma insulin and growth hormone in malnourished Jamaican children, during catch-up growth and after complete recovery
153. Studies of the secretion and metabolic effects of human growth hormone in children with glucocorticoid-induced growth retardation
154. Effect of dietary fat and calorie restriction on protein utilization
155. Diurnal variation in the responsiveness of human subjects to human growth hormone
156. Effect of intensive insulin treatment on linear growth in the young diabetic patient
157. Somatomedin and growth after renal transplantation
158. Investigation with a partially purified preparation of serum sulfation factor: lack of specificity for cartilage sulfation
159. Effects of somatomedin on cartilage metabolism: further observations on an inhibitory serum factor
160. Interaction of somatomedin and a peptide inhibitor in serum of hypohpysectomized and starved, pituitary-intact rats
161. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro
162. Insulin as a growth hormone
163. Continuous ambulatory peritoneal dialysis in children
164. ‘Typical’ and ‘atypical’ serum insulin-like activity in untreated diabetes mellitus
165. Growth hormone secretion in growth-retarded asthmatic children
166. The distribution of somatomedins in the nervous system of the cat and their release following neural stimulation
167. Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver
168. The effect of renal impairment on growth in the rat: relationship to malnutrition and serum somatomedin levels
169. Serum somatomedin activity measured as sulphation factor in peripheral, hepatic, and renal veins of mongrel dogs: basal levels
170. Somatomedin activity measured as sulphation factor in culture media from normal human liver and connective tissue explants. Effects on human growth
171. Somatomedin production in normal adults and cirrhosis patients
172. The histology and in vivo sulphate uptake of epiphyseal cartilage in protein-depleted rats
173. Generation of somatomedin activity in response to growth hormone and insulin from isolated perfused livers of normal and protein-malnourished rats
174. Relation of caloric deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation
175. Juvenile Cushing's syndrome manifested primarily by growth failure
176. Synthesis by cultured hepatocytes of somatomedin and its binding protein
177. Growth impairment with elevated somatomedin levels in children with chronic renal insufficiency
178. Relationship of growth hormone to the growth retardation associated with maternal dietary restriction
179. Growth retardation in Cushing's syndrome
180. Serum somatomedin and growth hormone levels in chronic renal failure
181. Cortisol and growth hormone secretion in relation to linear growth: patients with Still's disease on different therapeutic regimens
182. Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease
183. Effect of growth hormone and nutrition on the level of somatomedin A in the rat
184. Serum somatomedin A in chronic renal failure
185. Somatomedin A in various clinical conditions in man
186. Effect of nutrition on growth and somatomedin A levels in the rat
187. Insulin-infusion-pump treatment of diabetes. Influence of improved metabolic control on plasma somatomedin levels
188. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain
189. Growth as a monitor of nutritional status
190. Growth in diabetic children. Studies in identical twins
191. Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effect of prednisone
192. Somatomedin A levels in patients with Cushing's disease
193. Adipose tissue development, growth and food consumption in protein-malnourished rats
194. Steroid-induced somatomedin inhibitors
195. Influence of liver resection and regeneration on somatomedin (sulphation factor). Activity in sera from normal and hypophysectomized rats
196. Plasma somatomedin activity in children with growth disturbances
197. Further observations on plasma somatomedin activity in children
198. Liver somatomedin activity in diabetic rats
199. Extraction of somatomedin activity from rat liver
200. Nutrition and somatomedin. VII. Regulation of somatomedin activity by the perfused rat liver
201. Alterations in thyroid function with systemic illness: the ‘euthyroid-sick syndrome’
202. Protein malnutrition in children: advances in knowledge in the last ten years
203. Energy costs and protein requirements for catch-up growth in children
204. An attempt to elucidate the cause of growth retardation in renal disease
205. Protein and energy requirements of young children living in the developing countries to allow for catch-up growth after infections
206. Infection, nutrition and growth in a rural African environment
207. Some effects of accelerating growth. I. General somatic development
208. Glycosylated hemoglobin levels in children with diabetes mellitus
209. Cellular response in rats during malnutrition at various ages
210. Nutrition and cell growth
211. Somatomedin actvitiy and diabetic control in children with insulin-dependent diabetes
212. Somatomedin activity in the Mauriac syndrome
213. Obesity in childhood: a study of the birth weight, the height, and the onset of puberty
214. Reduced serum somatomedin activity in patients with chronic liver disease
215. The growth hormone dependent sulfation factor in serum from patients with various types of diabetes
216. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum
217. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders